Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core

NIH RePORTER · NIH · N01 · $2,501,263 · view on reporter.nih.gov ↗

Abstract

To design, implement and manage ethical and statistically sound clinical trials and human challenge studies for influenza vaccines, vaccine components and delivery systems developed by the NIAID Collaborative Influenza Vaccine Innovation Centers. Current efforts include a Phase I clinical trial.

Key facts

NIH application ID: 11041317
Project number: 75N93019C00054-P00015-9999-1
Recipient: DUKE UNIVERSITY
Principal Investigator: CHIP WALTER
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $2,501,263
Award type: —
Project period: 2019-09-16 → 2026-09-15